Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

BUY
$0.46 - $42.69 $184,287 - $17.1 Million
400,626 Added 200313.0%
400,826 $200,000
Q4 2022

Jan 27, 2023

SELL
$0.46 - $42.69 $184,287 - $17.1 Million
-400,626 Reduced 99.95%
200 $0
Q4 2020

Mar 01, 2021

BUY
$0.76 - $1.47 $304,627 - $589,214
400,826 New
400,826 $545,000

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $134M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Main Street Financial Solutions, LLC Portfolio

Follow Main Street Financial Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Street Financial Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Main Street Financial Solutions, LLC with notifications on news.